We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+2.82%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$231B
AUM Growth
-$701M
Cap. Flow
-$4.96B
Cap. Flow %
-2.15%
Top 10 Hldgs %
13.13%
Holding
8,738
New
866
Increased
3,703
Reduced
3,052
Closed
702

Top Sells

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$514M
2
MDLZ icon
Mondelez International
MDLZ
+$421M
3
COR icon
Cencora
COR
+$225M
4
IVZ icon
Invesco
IVZ
+$212M
5
MON
Monsanto Co
MON
+$205M

Sector Composition

Rank Sector Weight
1 Technology 8.74%
2 Financials 7.28%
3 Healthcare 6.05%
4 Consumer Discretionary 5.36%
5 Energy 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LBRT icon
6251
Liberty Energy
LBRT
$3.27B
$35K ﹤0.01%
+1,891
New +$37.1K
LTL icon
6252
ProShares Ultra Communication Services
LTL
$6.52M
$35K ﹤0.01%
3,740
-608
-14% -$5.7K
NERV icon
6253
Minerva Neurosciences
NERV
$207M
$35K ﹤0.01%
534
+418
+360% +$25.4K
PARAA
6254
DELISTED
Paramount Global Class A
PARAA
$35K ﹤0.01%
618
-1,695
-73% -$89K
PLPC icon
6255
Preformed Line Products
PLPC
$2.25B
$35K ﹤0.01%
391
-1,596
-80% -$118K
RYZ
6256
Ryerson Holding Corp
RYZ
$1.4B
$35K ﹤0.01%
3,106
-38
-1% -$417
QTTB icon
6257
Q32 Bio
QTTB
$482M
$35K ﹤0.01%
+95
New +$34K
SBT
6258
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
$35K ﹤0.01%
2,591
+2,580
+23,455% +$34.9K
AIU
6259
DELISTED
Meta Data Limited American Depositary Shares, each representing ten (10) Class A Ordinary Shares
AIU
$35K ﹤0.01%
25
-30,524
-100% -$45.2M
HALL
6260
DELISTED
Hallmark Financial Services, Inc.
HALL
$35K ﹤0.01%
353
+213
+152% +$21.1K
AMAG
6261
DELISTED
AMAG Pharmaceuticals
AMAG
$35K ﹤0.01%
1,791
-132,599
-99% -$2.93M
BUY
6262
DELISTED
USCF SummerHaven SHPEI Index Fund
BUY
$35K ﹤0.01%
1,304
+106
+9% +$2.8K
LDF
6263
DELISTED
Latin American Discovery Fund
LDF
$35K ﹤0.01%
3,717
+15
+0.4% +$162
NATH icon
6264
Nathan's Famous
NATH
$403M
$34K ﹤0.01%
+363
New +$30.1K
NRIM icon
6265
Northrim BanCorp
NRIM
$591M
$34K ﹤0.01%
+3,480
New +$32.8K
NTIC icon
6266
Northern Technologies International Corp
NTIC
$77.8M
$34K ﹤0.01%
1,922
-22
-1% -$332
SACH
6267
Sachem Capital Corp
SACH
$39.8M
$34K ﹤0.01%
8,126
+126
+2% +$472
VSDA icon
6268
VictoryShares Dividend Accelerator ETF
VSDA
$250M
$34K ﹤0.01%
1,207
GPP
6269
DELISTED
Green Plains Partners LP
GPP
$34K ﹤0.01%
2,000
-324,625
-99% -$5.61M
FSTX
6270
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$34K ﹤0.01%
724
+200
+38% +$11.1K
FNHC
6271
DELISTED
FedNat Holding Company Common Stock
FNHC
$34K ﹤0.01%
1,466
-19
-1% -$377
RNET
6272
DELISTED
RigNet, Inc.
RNET
$34K ﹤0.01%
3,345
+3,327
+18,483% +$44K
AIV.PRA
6273
DELISTED
Apart. Invst and Mgt Co
AIV.PRA
$34K ﹤0.01%
1,334
+573
+75% +$14.9K
LTN.U
6274
DELISTED
Union Acquisition Corp.
LTN.U
$34K ﹤0.01%
3,315
+675
+26% +$6.9K
DRR
6275
DELISTED
Market Vectors Double Short Euro ETN
DRR
$34K ﹤0.01%
644
-934
-59% -$47.6K

Similar funds

UBS Group's Q2 2018 Portfolio in Review

As of Q2 2018, UBS Group held 8,738 positions worth $231B, down 0.3% from $232B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q2 2018 filing shows 866 new, 3,703 increased, 3,052 reduced and 702 closed positions. Its largest new stake was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M. The largest sale was NXP Semiconductors, an estimated $514M.

By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 8.1% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2018 buy was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $1.01B increase.
  • UBS Group's biggest Q2 2018 reduction was NXP Semiconductors, cutting an estimated $514M.
  • UBS Group fully exited Monsanto Co in Q2 2018, selling an estimated $205M.
  • UBS Group's ten largest holdings make up 13% of its $231B portfolio in Q2 2018.
  • UBS Group opened 866 new positions and closed 702 in Q2 2018.
  • UBS Group's portfolio value fell 0.3% quarter-over-quarter to $231B.

Based on UBS Group's 13F filing for Q2 2018, filed 14 Aug 2018.